Cutler Group LLC / CA - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2023$2
-100.0%
1,500
-94.9%
0.00%
-100.0%
Q4 2021$146,000
+1522.2%
29,200
+3550.0%
0.01%
Q3 2021$9,000
-43.8%
800
-77.8%
0.00%
-100.0%
Q2 2021$16,000
-27.3%
3,600
+350.0%
0.00%0.0%
Q1 2021$22,000
-4.3%
800
-20.0%
0.00%0.0%
Q4 2020$23,000
-30.3%
1,0000.0%0.00%
-50.0%
Q3 2020$33,000
-21.4%
1,0000.0%0.00%
-33.3%
Q2 2020$42,000
-35.4%
1,000
-81.8%
0.00%0.0%
Q1 2020$65,000
-72.6%
5,500
-16.7%
0.00%
-78.6%
Q4 2019$237,000
+139.4%
6,600
+112.9%
0.01%
+55.6%
Q3 2019$99,000
+20.7%
3,100
+24.0%
0.01%
+12.5%
Q2 2019$82,000
-31.7%
2,500
-30.6%
0.01%
-33.3%
Q1 2019$120,000
-37.5%
3,600
-71.4%
0.01%
-33.3%
Q4 2018$192,000
-24.7%
12,600
-19.7%
0.02%0.0%
Q3 2018$255,000
+363.6%
15,700
-0.6%
0.02%
+350.0%
Q2 2018$55,000
-83.4%
15,800
-15.1%
0.00%
-85.7%
Q1 2018$331,000
+55.4%
18,600
-35.4%
0.03%
+211.1%
Q4 2017$213,000
+53.2%
28,800
+89.9%
0.01%
+80.0%
Q3 2017$139,000
-84.1%
15,166
-84.2%
0.01%
-84.4%
Q2 2017$875,000
+50.3%
95,949
-30.1%
0.03%
+28.0%
Q1 2017$582,000
+94.0%
137,245
+300.5%
0.02%
+127.3%
Q4 2016$300,000
+91.1%
34,266
+69.2%
0.01%
+57.1%
Q3 2016$157,000
+57.0%
20,255
+88.3%
0.01%
+40.0%
Q2 2016$100,000
-47.1%
10,755
-75.0%
0.01%
-58.3%
Q1 2016$189,000
+37.0%
43,046
+193.3%
0.01%
+71.4%
Q4 2015$138,00014,6780.01%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 2,679,835$69,675,00019.39%
Endurant Capital Management LP 207,293$5,390,0001.94%
Bellevue Group AG 5,138,451$133,599,0001.53%
Rhenman & Partners Asset Management AB 592,225$15,398,0001.26%
PLATINUM INVESTMENT MANAGEMENT LTD 1,562,869$40,635,0000.93%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 31,434$817,0000.62%
WASATCH ADVISORS LP 3,998,010$103,949,0000.51%
HAMILTON LANE ADVISORS LLC 46,181$1,201,0000.45%
Boxer Capital, LLC 500,000$13,000,0000.42%
DCF Advisers, LLC 38,500$1,001,0000.41%
View complete list of ESPERION THERAPEUTICS INC NE shareholders